Cwm LLC Trims Stock Position in ARK Genomic Revolution ETF $ARKG

Cwm LLC lessened its holdings in shares of ARK Genomic Revolution ETF (BATS:ARKG) by 1.2% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 37,677 shares of the company’s stock after selling 462 shares during the period. Cwm LLC owned approximately 0.08% of ARK Genomic Revolution ETF worth $917,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also recently made changes to their positions in ARKG. Cambridge Investment Research Advisors Inc. raised its holdings in shares of ARK Genomic Revolution ETF by 0.9% during the first quarter. Cambridge Investment Research Advisors Inc. now owns 94,117 shares of the company’s stock worth $1,954,000 after purchasing an additional 839 shares during the last quarter. Oppenheimer & Co. Inc. purchased a new position in shares of ARK Genomic Revolution ETF during the first quarter worth $387,000. Crescent Grove Advisors LLC raised its holdings in shares of ARK Genomic Revolution ETF by 13.2% during the first quarter. Crescent Grove Advisors LLC now owns 34,539 shares of the company’s stock worth $717,000 after purchasing an additional 4,030 shares during the last quarter. McGuire Investment Group LLC raised its holdings in shares of ARK Genomic Revolution ETF by 72.6% during the first quarter. McGuire Investment Group LLC now owns 20,052 shares of the company’s stock worth $416,000 after purchasing an additional 8,432 shares during the last quarter. Finally, Ameritas Advisory Services LLC raised its holdings in shares of ARK Genomic Revolution ETF by 5.8% during the first quarter. Ameritas Advisory Services LLC now owns 42,655 shares of the company’s stock worth $886,000 after purchasing an additional 2,357 shares during the last quarter.

ARK Genomic Revolution ETF Stock Performance

ARKG stock opened at $32.63 on Wednesday. The firm’s fifty day moving average is $27.30 and its 200 day moving average is $24.39. ARK Genomic Revolution ETF has a one year low of $17.51 and a one year high of $31.16.

ARK Genomic Revolution ETF Company Profile

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.